民生证券担任联席主承销商的多只债券成功发行

Group 1 - The issuance of bonds "25金丰V1", "25金丰V2", "25泰华02", and "25泰华03" was successfully completed, with a total scale of 5.8 billion yuan for the rural revitalization bonds [1] - The issuer, Jinfeng Industrial Development Investment Group, plays a significant role in the regional economic development, focusing on the production and sales of aluminum fluoride and water supply [1] - The bonds had strong subscription rates, with "25金丰V1" having a subscription multiple of 5.86 times and "25金丰V2" at 4.13 times [1] Group 2 - Taizhou Huaxin Pharmaceutical Investment Co., Ltd. focuses on the integration of investment, construction, and operation in the health industry, with a main business in pharmaceutical health, infrastructure development, and urban commercial services [2] - The company aims to create a comprehensive biopharmaceutical industry chain in the Yangtze River Delta region, encompassing various functions such as drug research, exhibition trading, production, and healthcare [2] - Minsheng Securities actively assisted the issuer in communication with regulatory authorities, aiming to create a low-cost and efficient financing environment for the issuer [2]